<DOC>
	<DOC>NCT02309671</DOC>
	<brief_summary>This trial investigates the effects of several doses of FE 999049 in Japanese women undergoing IVF/ICSI treatment.</brief_summary>
	<brief_title>A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Women diagnosed with tubal infertility, unexplained infertility, infertility related to endometriosis stage I/II or with partners diagnosed with male factor infertility Women eligible for IVF and/or ICSI treatment Women aged 2039 years Women with body mass index (BMI) of 17.532.0 kg/m2 Women with polycystic ovary syndrome (PCOS) associated with anovulation, endometriosis stage III/IV Women with history of recurrent miscarriage Women with contraindications to controlled ovarian stimulation with gonadotropins Women with three or more controlled ovarian stimulation cycles</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>